Biological Psychiatry
Volume 61, Issue 10 , Pages 1215-1217 , 15 May 2007

Antibodies to Infectious Agents in Individuals at Ultra-High Risk for Psychosis

  • G. Paul Amminger

      Affiliations

    • ORYGEN Research Centre (incorporating the Personal Assistance and Crises Evaluation [PACE] Clinic), Department of Psychiatry, University of Melbourne, Australia
    • Department of Child and Adolescent Psychiatry, Medical University of Vienna, Austria
    • Corresponding Author InformationAddress reprint requests to Dr. G. Paul Amminger, Department of Child and Adolescent Psychiatry, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • Patrick D. McGorry

      Affiliations

    • ORYGEN Research Centre (incorporating the Personal Assistance and Crises Evaluation [PACE] Clinic), Department of Psychiatry, University of Melbourne, Australia
    • ,
  • Gregor E. Berger

      Affiliations

    • ORYGEN Research Centre (incorporating the Personal Assistance and Crises Evaluation [PACE] Clinic), Department of Psychiatry, University of Melbourne, Australia
    • ,
  • Darryl Wade

      Affiliations

    • ORYGEN Research Centre (incorporating the Personal Assistance and Crises Evaluation [PACE] Clinic), Department of Psychiatry, University of Melbourne, Australia
    • ,
  • Alison R. Yung

      Affiliations

    • ORYGEN Research Centre (incorporating the Personal Assistance and Crises Evaluation [PACE] Clinic), Department of Psychiatry, University of Melbourne, Australia
    • ,
  • Lisa J. Phillips

      Affiliations

    • ORYGEN Research Centre (incorporating the Personal Assistance and Crises Evaluation [PACE] Clinic), Department of Psychiatry, University of Melbourne, Australia
    • ,
  • Susy M. Harrigan

      Affiliations

    • ORYGEN Research Centre (incorporating the Personal Assistance and Crises Evaluation [PACE] Clinic), Department of Psychiatry, University of Melbourne, Australia
    • ,
  • Shona M. Francey

      Affiliations

    • ORYGEN Research Centre (incorporating the Personal Assistance and Crises Evaluation [PACE] Clinic), Department of Psychiatry, University of Melbourne, Australia
    • ,
  • Robert H. Yolken

      Affiliations

    • John Hopkins University School of Medicine, Stanley Division of Developmental Neurovirology, Baltimore, Maryland.

Received 12 November 2005 ,Revised 26 September 2006 ,Accepted 29 September 2006.

References 

  1. Andreasen NC. Negative symptoms in schizophrenia (Definition and reliability). Arch Gen Psychiatry. 1982;39:784–788
  2. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61:774–780
  3. Brown AS, Cohen P, Harkavy-Friedman J, Babulas V, Malaspina D, Gorman JM, et al. A.E. Bennett Research Award (Prenatal rubella, premorbid abnormalities, and adult schizophrenia). Biol Psychiatry. 2001;49:473–486
  4. Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry. 2005;162:767–773
  5. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry. 2001;58:1032–1037
  6. Cubitt WD, Ades AE, Peckham CS. Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii. J Clin Pathol. 1992;45:435–438
  7. Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis?. Biol Psychol. 2003;63:253–268
  8. Kramer W. Frontiers of neurological diagnosis in acquired toxoplasmosis. Psychiatr Neurol Neurochir. 1966;69:43–64
  9. Leweke FM, Gerth CW, Koethe D, Klosterkotter J, Ruslanova I, Krivogorsky B, et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:4–8
  10. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921–928
  11. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799–812
  12. Rigsby P, Rijpkema S, Guy EC, Francis J, Das RG. Evaluation of a candidate international standard for human anti-Toxoplasma immunoglobulin G. J Clin Microbiol. 2004;42:5133–5138
  13. Sauerbrei A, Wutzler P. Serological detection of type-specific IgG to herpes simplex virus by novel ELISAs based on recombinant and highly purified glycoprotein G. Clin Lab. 2004;50:425–429
  14. Sever JL, Ellenberg JH, Ley AC, Madden DL, Fuccillo DA, Tzan NR, et al. Toxoplasmosis: maternal and pediatric findings in 23,000 pregnancies. Pediatrics. 1988;82:181–192
  15. Stibbs HH. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol. 1985;79:153–157
  16. Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats?. Schizophr Bull. 1995;21:167–171
  17. Torrey EF, Yolken RH. Toxoplasma gondii and schizophrenia. Emerg Infect Dis. 2003;9:1375–1380
  18. Walzer PD, Genta RM. Toxoplasma gondii. Parasitic infection in the compromised host. Marcel Dekker, Inc: New York; 1989;
  19. Yolken R. Viruses and schizophrenia: a focus on herpes simplex virus. Herpes Suppl. 2004;11:83A–88A
  20. Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis. 2001;32:842–844
  21. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, et al. Prediction of psychosis (A step towards indicated prevention of schizophrenia). Br J Psychiatry Suppl. 1998;172:14–20

PII: S0006-3223(06)01273-X

doi: 10.1016/j.biopsych.2006.09.034

Biological Psychiatry
Volume 61, Issue 10 , Pages 1215-1217 , 15 May 2007

Article Tools

* Image Usage & Resolution